Replies to post #21624 on Biotech Values

[DewDiligence]

Re: AVGN

Touting a lead molecule whose identity hasn’t yet been disclosed strikes me as an act of desperation. Investors need to have more than the usual modicum of trust to buy into a scheme like this. JMHO, FWIW